Obtaining the prestigious PMDA certification in Japan.
After more than two years of intense work, we are proud to announce the obtaining of the prestigious authorization to sell for EchoS device in Japan issued by the PMDA Japan: Pharmaceuticals and Medical Devices Agency of Japan.
The important milestone is a further international recognition for Echolight obtained through a scrupulous work with the Japanese agency and the commercial partner Toyo Medic, a consolidated reality in the distribution of innovative medical devices that has signed an important exclusive sales agreement in the Japanese territory for the Echolight range of products.
In Japan, the issue of bone health is so crucial that the Japanese Ministry of Health, Labor and Welfare has undertaken a survey to quantify the costs related to deficiencies in bone density and structure, as well as the costs related to fractures in the older population. age 65 and it has been estimated that total costs have been nearly 944 billion Japanese yen (8 billion US dollars) and are increasing rapidly.
With the introduction of R.E.M.S. Japan is at the forefront in the diagnosis of osteoporosis, demonstrating its foresight by adopting a new concept of bone health based on prevention, early diagnosis and monitoring throughout the whole life aimed at reducing the risk of fragility fracture with direct benefits towards patients as well as the sustainability of their healthcare system.
In fact, the revolutionary EchoS device, for bone micro-architecture assessment of the lumbar vertebrae and the femoral neck, based on the proprietary and patented R.E.M.S. (Radiofrequency Echographic Multi Spectrometry), being radiation-free, fast, portable and accurate, it significantly increases the accessibility to the test for the entire Japanese population, favoring prevention and early diagnosis.
The expansion of Echolight and the adoption of R.E.M.S. by an ever-growing number of countries, now numbering over 40 around the world.
For more information:
R.E.M.S. technology reaches the oceanic continent. We are proud to announce the achievement of sales authorization for the Echolight products issued by the Australia Government Department of Health. So Australia is also opening its doors to R.E.M.S. (Radiofrequency...
Echolight joins National Osteoporosis Foundation's Corporate Advisory Roundtable Innovator in bone density diagnostic technology brings expertise to foundation. SEATTLE, Feb. 23, 2021 /PRNewswire/ -- Echolight Medical, manufacturer of the radiation-free EchoS portable...
Radiofrequency Echographic Multi Spectrometry officially enters Wikipedia. Echolight is pleased to announce that REMS technology enters Wikipedia, the free, online and collaborative Encyclopedia, which thanks to the contribution of volunteers from around the world is...